Search Results
Results found for "Keltic Pharma Therapeutics"
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
The canonical assumption that targeting PLC would be therapeutic has failed in the clinic, and patients
- Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem
Later hepatotoxicity concerns and the success of antibody therapeutics further shifted strategy.
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
has reached only about 166 of them, leaving more than 250 receptors unstudied at anything close to therapeutic
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
symptomatic of a deeper challenge: the field has not yet fully characterized which signaling pathways produce therapeutic
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
activation, and resistant to pharmacological blockade - and why those properties have shaped both the therapeutic
- Lin and Ball: GPCR Antibody Characterization and the Recombinant Shift | Dr. GPCR Ecosystem
research 36:55 If not antibodies - Ball and Lin on the power of scientific communication 39:40 The GPCR therapeutic
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
. 💊 Therapeutic Potential : Understanding bias enables researchers to design drugs that target specific Kenakin challenges the traditional approach and encourages leveraging bias for better therapeutic outcomes
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
visualization to become quantitative tools for understanding receptor activation and guiding GPCR-targeted therapeutics










